Vanguard Group Inc Vericel Corp Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Vericel Corp stock. As of the latest transaction made, Vanguard Group Inc holds 3,483,896 shares of VCEL stock, worth $207 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,483,896
Previous 3,444,682
1.14%
Holding current value
$207 Million
Previous $158 Million
6.86%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding VCEL
# of Institutions
277Shares Held
48.4MCall Options Held
91.8KPut Options Held
23.2K-
Black Rock Inc. New York, NY8.06MShares$479 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD3.83MShares$228 Million3.54% of portfolio
-
State Street Corp Boston, MA2.43MShares$145 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.37MShares$141 Million0.02% of portfolio
-
Conestoga Capital Advisors, LLC2.08MShares$124 Million1.21% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.81B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...